000 01606 a2200493 4500
005 20250514185918.0
264 0 _c20040817
008 200408s 0 0 eng d
022 _a1075-2765
024 7 _a10.1097/00045391-200405000-00010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWu, Kuei-Meng
245 0 0 _aRegulatory toxicology perspectives on the development of botanical drug products in the United States.
_h[electronic resource]
260 _bAmerican journal of therapeutics
_c
300 _a213-7 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aCarcinogenicity Tests
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrugs, Investigational
_xadverse effects
650 0 4 _aHumans
650 0 4 _aMutagenicity Tests
650 0 4 _aPlant Preparations
_xadverse effects
650 0 4 _aToxicology
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aFarrelly, James
700 1 _aBirnkrant, Debra
700 1 _aChen, Shaw
700 1 _aDou, Jinhui
700 1 _aAtrakchi, Aisar
700 1 _aBigger, Anita
700 1 _aChen, Conrad
700 1 _aChen, Zhou
700 1 _aFreed, Lois
700 1 _aGhantous, Hanan
700 1 _aGoheer, Anwar
700 1 _aHausner, Elizabeth
700 1 _aOsterberg, Robert
700 1 _aRhee, Herman
700 1 _aZhang, Ke
773 0 _tAmerican journal of therapeutics
_gvol. 11
_gno. 3
_gp. 213-7
856 4 0 _uhttps://doi.org/10.1097/00045391-200405000-00010
_zAvailable from publisher's website
999 _c14843186
_d14843186